VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/06/14 -- PDC Biological Health Group Corporation (CSE: PHG) ("PDC" or the "Company") announces that, effective July 31, 2014, Shelley Leonhardt has resigned as the Chief Operating Officer and a director of the Company. The Company wishes to thank Ms. Leonhardt for her contribution and service to the Company.
About PDC
PDC's primary product, the CRT 2000 Thermographic System, is a non-invasive, radiation-free, reproducible thermographic tool that measures the temperature of predetermined skin points and analyzes such data to provide a health care practitioner with information that may be indicative of irregular body function. The CRT 2000 Thermographic System is intended for use in preventive healthcare. The CRT 2000 Thermographic System is presently ready for sale; it has obtained the CE Safety Mark (TUV) the FDA premarket notification Class I (510(k)) and is certified as a Class II medical device by the Chinese health authority (SFDA).
Neither the Canadian Securities Exchange (CSE) nor its Regulation Services Providers (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
PDC Biological Health Group Corporation
Bernard Armani
President and CEO
604-304-6006
www.biologicalhealthgroup.com
